• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病非运动症状量表的韩文版验证。

Validation of the korean-version of the nonmotor symptoms scale for Parkinson's disease.

机构信息

Department of Neurology, Korea University College of Medicine, Seoul, Korea.

出版信息

J Clin Neurol. 2012 Dec;8(4):276-83. doi: 10.3988/jcn.2012.8.4.276. Epub 2012 Dec 21.

DOI:10.3988/jcn.2012.8.4.276
PMID:23323136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3540287/
Abstract

BACKGROUND AND PURPOSE

Non-motor symptoms are common in Parkinson's disease (PD), and are the primary cause of disability in many PD patients. Our aim in this study was to translate the origin non-motor symptoms scale for PD (NMSS), which was written in English, into Korean (K-NMSS), and to evaluate its reliability and validity for use with Korean-speaking patients with PD.

METHODS

In total, 102 patients with PD from 9 movement disorders sections of university teaching hospitals in Korea were enrolled in this study. They were assessed using the K-NMSS, the Unified Parkinson's Disease Rating Scale (UPDRS), the Korean version of the Mini-Mental Status Examination (K-MMSE), the Korean version of the Montgomery-Asberg Depression Rating Scale (K-MADS), the Epworth Sleepiness Scale (ESS), and Parkinson's Disease Questionnaire 39 (PDQ39). Test-retest reliability was assessed over a time interval of 10-14 days in all but one patient.

RESULTS

The K-NMSS was administered to 102 patients with PD. The internal consistency and reliability of this tool was 0.742 (mean Cronbach's α-coefficient). The test-retest correlation reliability was 0.941 (Guttman split-half coefficient). There was a moderate correlation between the total K-NMSS score and the scores for UPDRS part I [Spearman's rank correlation coefficient, (rS)=0.521, p<0.001] and UPDRS part II (rS=0.464, p=0.001), but there was only a weak correlation between the total K-NMSS score and the UPDRS part III score (rS=0.288, p=0.003). The total K-NMSS score was significantly correlated with the K-MADS (rS=0.594, p<0.001), K-MMSE (rS=-0.291, p=0.003), and ESS (rS=0.348, p<0.001). The total K-NMSS score was also significantly and positively correlated with the PDQ39 score (rS=0.814, p<0.001).

CONCLUSIONS

The K-NMSS exhibited good reliability and validity for the assessment of non-motor symptoms in Korean PD patients.

摘要

背景与目的

非运动症状是帕金森病(PD)的常见症状,也是许多 PD 患者致残的主要原因。本研究旨在将英文版的起源非运动症状量表(NMSS)翻译成韩语(K-NMSS),并评估其在韩国 PD 患者中的信度和效度。

方法

本研究共纳入了韩国 9 家大学附属医院的运动障碍科的 102 名 PD 患者。他们接受了 K-NMSS、统一帕金森病评定量表(UPDRS)、简易精神状态检查量表(K-MMSE)、蒙哥马利-阿斯伯格抑郁评定量表(K-MADS)、Epworth 嗜睡量表(ESS)和帕金森病问卷 39(PDQ39)的评估。除 1 名患者外,其余患者在 10-14 天的时间间隔内进行了两次测试,以评估其重测信度。

结果

102 名 PD 患者接受了 K-NMSS 的评估。该工具的内部一致性和可靠性为 0.742(平均 Cronbach's α 系数)。测试-重测相关性可靠性为 0.941(Guttman 分割半系数)。K-NMSS 总分与 UPDRS 第 I 部分[Spearman 秩相关系数(rS)=0.521,p<0.001]和 UPDRS 第 II 部分(rS=0.464,p=0.001)的评分呈中度相关,但与 UPDRS 第 III 部分的评分仅呈弱相关(rS=0.288,p=0.003)。K-NMSS 总分与 K-MADS(rS=0.594,p<0.001)、K-MMSE(rS=-0.291,p=0.003)和 ESS(rS=0.348,p<0.001)呈显著正相关。K-NMSS 总分与 PDQ39 评分呈显著正相关(rS=0.814,p<0.001)。

结论

K-NMSS 对韩国 PD 患者非运动症状的评估具有良好的信度和效度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/3540287/83c70dc1c123/jcn-8-276-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/3540287/78e613490318/jcn-8-276-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/3540287/83c70dc1c123/jcn-8-276-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/3540287/78e613490318/jcn-8-276-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/3540287/83c70dc1c123/jcn-8-276-g002.jpg

相似文献

1
Validation of the korean-version of the nonmotor symptoms scale for Parkinson's disease.帕金森病非运动症状量表的韩文版验证。
J Clin Neurol. 2012 Dec;8(4):276-83. doi: 10.3988/jcn.2012.8.4.276. Epub 2012 Dec 21.
2
Translation and validation of the korean version of the 39-item Parkinson's disease questionnaire.帕金森病 39 项问卷韩文版的翻译与验证。
J Clin Neurol. 2013 Jan;9(1):26-31. doi: 10.3988/jcn.2013.9.1.26. Epub 2013 Jan 3.
3
Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep.帕金森病睡眠结局量表(韩文版)的验证。
J Korean Med Sci. 2018 Jan 8;33(2):e14. doi: 10.3346/jkms.2018.33.e14.
4
Validation of the Korean Version of the Scale for Outcomes in Parkinson's Disease-Autonomic.帕金森病自主神经功能障碍结局量表韩文版的验证
J Mov Disord. 2017 Jan;10(1):29-34. doi: 10.14802/jmd.16057. Epub 2017 Jan 18.
5
Validation of the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale.帕金森病评定量表中冲动控制障碍问卷韩文版的验证
J Clin Neurol. 2020 Apr;16(2):245-253. doi: 10.3988/jcn.2020.16.2.245.
6
Validation of the Non-Motor Symptoms Scale for Parkinson's Disease of Persian Version.帕金森病非运动症状量表波斯语版本的验证
Parkinsons Dis. 2023 Jun 9;2023:1972034. doi: 10.1155/2023/1972034. eCollection 2023.
7
Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.帕金森病非运动症状量表意大利语版本的验证
Parkinsonism Relat Disord. 2017 Jan;34:38-42. doi: 10.1016/j.parkreldis.2016.10.020. Epub 2016 Oct 24.
8
Non-Motor Symptoms as Predictors of Quality of Life in Egyptian Patients With Parkinson's Disease: A Cross-Sectional Study Using a Culturally Adapted 39-Item Parkinson's Disease Questionnaire.非运动症状作为埃及帕金森病患者生活质量的预测指标:一项使用文化适应性39项帕金森病问卷的横断面研究
Front Neurol. 2018 May 24;9:357. doi: 10.3389/fneur.2018.00357. eCollection 2018.
9
Evaluation of an Arabic version of the non-motor symptoms scale in Parkinson's disease.帕金森病非运动症状量表阿拉伯语版本的评估
Neurol Sci. 2016 Jun;37(6):963-8. doi: 10.1007/s10072-016-2525-x. Epub 2016 Mar 1.
10
Validation of the Chinese non-motor symptoms scale for Parkinson's disease: results from a Chinese pilot study.帕金森病中国非运动症状量表的验证:一项中国试点研究的结果
Clin Neurol Neurosurg. 2009 Jul;111(6):523-6. doi: 10.1016/j.clineuro.2009.02.005. Epub 2009 Mar 17.

引用本文的文献

1
Fatigue in Parkinson's Disease Is Due to Decreased Efficiency of the Frontal Network: Quantitative EEG Analysis.帕金森病中的疲劳归因于额叶网络效率降低:定量脑电图分析。
J Mov Disord. 2024 Jul;17(3):304-312. doi: 10.14802/jmd.24038. Epub 2024 Jun 10.
2
Effectiveness of Live-Streaming Tele-Exercise Intervention in Patients With Parkinson's Disease: A Pilot Study.帕金森病患者直播远程运动干预的有效性:一项试点研究。
J Mov Disord. 2024 Apr;17(2):189-197. doi: 10.14802/jmd.23251. Epub 2024 Feb 29.
3
Subjective cognitive complaints in patients with progressive supranuclear palsy.

本文引用的文献

1
The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.帕金森病患者非运动症状对健康相关生活质量的影响。
Mov Disord. 2011 Feb 15;26(3):399-406. doi: 10.1002/mds.23462. Epub 2011 Jan 24.
2
The challenge of non-motor symptoms in Parkinson's disease.帕金森病非运动症状的挑战。
Prog Brain Res. 2010;184:325-41. doi: 10.1016/S0079-6123(10)84017-8.
3
Levodopa in the treatment of Parkinson's disease: an old drug still going strong.左旋多巴治疗帕金森病:老药仍在发挥强大作用。
进行性核上性麻痹患者的主观认知主诉
Front Neurol. 2023 Dec 14;14:1326571. doi: 10.3389/fneur.2023.1326571. eCollection 2023.
4
Validation of the Non-Motor Symptoms Scale for Parkinson's Disease of Persian Version.帕金森病非运动症状量表波斯语版本的验证
Parkinsons Dis. 2023 Jun 9;2023:1972034. doi: 10.1155/2023/1972034. eCollection 2023.
5
Mild cognitive impairment is associated with poor gait performance in patients with Parkinson's disease.轻度认知障碍与帕金森病患者的步态表现不佳有关。
Front Aging Neurosci. 2022 Oct 4;14:1003595. doi: 10.3389/fnagi.2022.1003595. eCollection 2022.
6
Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson's disease: A systematic review and meta-analysis.帕金森病下尿路症状、尿失禁及尿潴留的患病率:一项系统评价与荟萃分析
Front Aging Neurosci. 2022 Sep 12;14:977572. doi: 10.3389/fnagi.2022.977572. eCollection 2022.
7
Constipation is Associated With Mild Cognitive Impairment in Patients With de novo Parkinson's Disease.便秘与新发帕金森病患者的轻度认知障碍有关。
J Mov Disord. 2022 Jan;15(1):38-42. doi: 10.14802/jmd.21074. Epub 2021 Nov 17.
8
Dance Intervention Using the Feldenkrais Method Improves Motor, and Non-Motor Symptoms and Gait in Parkinson's Disease: A 12-Month Study.运用费登奎斯方法的舞蹈干预改善帕金森病的运动和非运动症状及步态:一项为期12个月的研究。
J Mov Disord. 2022 Jan;15(1):53-57. doi: 10.14802/jmd.21086. Epub 2021 Nov 3.
9
Validation of the Korean version of the composite autonomic symptom scale 31 in patients with Parkinson's disease.验证帕金森病患者复合自主症状量表 31 的韩文版。
PLoS One. 2021 Oct 21;16(10):e0258897. doi: 10.1371/journal.pone.0258897. eCollection 2021.
10
Cardiac sympathetic burden reflects Parkinson disease burden, regardless of high or low orthostatic blood pressure changes.心脏交感神经负担反映帕金森病负担,无论体位性血压变化是高还是低。
NPJ Parkinsons Dis. 2021 Aug 12;7(1):71. doi: 10.1038/s41531-021-00217-3.
Clin Interv Aging. 2010 Sep 7;5:229-38. doi: 10.2147/cia.s6456.
4
Nonmotor fluctuations in Parkinson's disease: clinical spectrum and classification.帕金森病的非运动波动:临床谱和分类。
J Neurol Sci. 2010 Feb 15;289(1-2):89-92. doi: 10.1016/j.jns.2009.08.022. Epub 2009 Sep 10.
5
Validation of the Chinese non-motor symptoms scale for Parkinson's disease: results from a Chinese pilot study.帕金森病中国非运动症状量表的验证:一项中国试点研究的结果
Clin Neurol Neurosurg. 2009 Jul;111(6):523-6. doi: 10.1016/j.clineuro.2009.02.005. Epub 2009 Mar 17.
6
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.一种新型帕金森病非运动症状量表的度量特性:一项国际试点研究的结果
Mov Disord. 2007 Oct 15;22(13):1901-11. doi: 10.1002/mds.21596.
7
The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations.统一帕金森病评定量表(UPDRS):现状与建议
Mov Disord. 2003 Jul;18(7):738-50. doi: 10.1002/mds.10473.
8
Assessing health status and quality-of-life instruments: attributes and review criteria.评估健康状况和生活质量的工具:属性与评审标准
Qual Life Res. 2002 May;11(3):193-205. doi: 10.1023/a:1015291021312.
9
The clinical features of Parkinson's disease in 100 histologically proven cases.100例经组织学证实的帕金森病临床特征
Adv Neurol. 1993;60:595-9.
10
The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.帕金森病患者功能与幸福感简短测量方法的开发与验证
Qual Life Res. 1995 Jun;4(3):241-8. doi: 10.1007/BF02260863.